Skip to Content

Tag: CHF

Also Noted

ResMed announces positive results from study

May 27, 2016HME News Staff

FLORENCE, Italy - A new study shows adaptive servo-ventilation therapy results in significant improvement in the primary endpoint for people with heart failure with preserved ejection fraction who have sleep disordered breathing, ResMed has announced. “These results are important because they are the first to show that addressing sleep-disordered breathing with ASV therapy may improve cardiovascular outcomes for people with preserved ejection fraction heart failure,” said Glenn Richards,...

CHF, ResMed, Sleep Therapy, study

Read Full Articlered right arrow icon


ResMed 'plans to stay ahead of the game'

April 26, 2013Liz Beaulieu, Editor

SAN DIEGO - Despite pervasive reimbursement pressures, ResMed officials have reported solid earnings for the third quarter and outlined “major growth horizons” for the company's future.During an earnings call with investors on April 25, newly minted CEO Mick Farrell detailed ResMed's plan to drive market penetration in three markets: sleep disordered breathing, COPD and heart failure. “We are more excited than we have ever been,” he said.ResMed reported $383.6 million...

CHF, COPD, CPAP, FDA, Mick Farrell, ResMed

Read Full Articlered right arrow icon

Also Noted

Hospital readmissions 'frequent,' studies find

January 23, 2013HME News Staff

CHICAGO - A pair of studies published in the Journal of the American Medical Association (JAMA) this week explored some of the causes behind high hospital readmission rates for Medicare beneficiaries. One of the studies found that after discharge from acute care hospitals, emergency department visits within 30 days were common among adults and accounted for almost 40% of post-discharge hospital-based acute care visits. The study determined that improving care transitions should focus not only on...

CHF, Hospital readmission, JAMA, MI, Pneumonia

Read Full Articlered right arrow icon

Also Noted

Telehealth to expand rapidly over next five years, study says

January 22, 2013HME News Staff

NORTHAMPTON, U.K. - By 2017, the number of patients remotely monitored by their healthcare provider is expected to balloon to 1.8 million patients worldwide, according to a new study from InMedica, a medical technology research division of IMS Research. By contrast, in 2012, that number was 308,000, the study states. These patients are being monitored for diseases such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, hypertension and mental health conditions....

CHF, COPD, IMS Research, InMedica

Read Full Articlered right arrow icon